Advanced search
Publication Cover
Expert Opinion on Biological Therapy Volume 19, 2019 - Issue 2
Submit an article Journal homepage
415
Views
11
CrossRef citations to date
0
Altmetric
Drug Profile

Antimicrobial treatment with the fixed-dose antibiotic combination RHB-104 for Mycobacterium avium subspecies paratuberculosis in Crohn’s disease: pharmacological and clinical implications

Edoardo SavarinoGastrointestinal Unit, Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua, ItalyCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-3187-2894View further author information
ORCID Icon,
Lorenzo BertaniGastrointestinal Unit, Division of Gastroenterology, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, ItalyView further author information
,
Linda CeccarelliGastrointestinal Unit, Division of Gastroenterology, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, ItalyView further author information
,
Giorgia BodiniGastrointestinal Unit, Department of Internal Medicine and Medical Specialties, University of Genoa, Genoa, ItalyView further author information
,
Fabiana ZingoneGastrointestinal Unit, Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua, ItalyView further author information
,
Andrea BudaGastrointestinal Unit, Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua, ItalyView further author information
,
Sonia FacchinGastrointestinal Unit, Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua, ItalyView further author information
,
Greta LorenzonGastrointestinal Unit, Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua, ItalyView further author information
,
Santino MarchiGastrointestinal Unit, Division of Gastroenterology, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, ItalyORCID Iconhttps://orcid.org/0000-0003-3255-9864View further author information
ORCID Icon,
Elisa MarabottoGastrointestinal Unit, Department of Internal Medicine and Medical Specialties, University of Genoa, Genoa, ItalyView further author information
,
Nicola De BortoliGastrointestinal Unit, Division of Gastroenterology, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, ItalyView further author information
,
Vincenzo SavarinoGastrointestinal Unit, Department of Internal Medicine and Medical Specialties, University of Genoa, Genoa, ItalyORCID Iconhttps://orcid.org/0000-0002-3187-2894View further author information
ORCID Icon,
Francesco CostaGastrointestinal Unit, Division of Gastroenterology, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, ItalyView further author information
&
Corrado BlandizziUnit of Pharmacology and Pharmacovigilance, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, ItalyView further author information
 show all
Pages 79-88 | Received 30 Jan 2018, Accepted 17 Dec 2018, Published online: 02 Jan 2019

Citations (11)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Ellen S. Pierce, Paul Barkhaus, Morgan Beauchamp, Mark Bromberg, Gregory T. Carter, Jill Goslinga, David Greeley, Sky Kihuwa-Mani, Gleb Levitsky, Isaac Lund, Christopher McDermott, Gary Pattee, Kaitlyn Pierce, Meraida Polak, Dylan Ratner, Paul Wicks & Richard Bedlack. (2023) ALSUntangled #66: antimycobacterial antibiotics.. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 24:5-6, pages 539-543.
Read now

Articles from other publishers (10)

Kostas A. Triantaphyllopoulos. (2023) Long Non-Coding RNAs and Their “Discrete” Contribution to IBD and Johne’s Disease—What Stands out in the Current Picture? A Comprehensive Review. International Journal of Molecular Sciences 24:17, pages 13566.
Crossref
Taruna Mohinani, Aditya Saxena & Shoor Vir Singh. (2023) Computational Analysis to Predict Drug Targets for the Therapeutic Management of Mycobacterium avium sub. Paratuberculosis. Current Drug Discovery Technologies 20:4.
Crossref
Coad Thomas Dow & Briana Lizet Alvarez. (2022) Mycobacterium paratuberculosis zoonosis is a One Health emergency. EcoHealth 19:2, pages 164-174.
Crossref
Coad Thomas Dow. (2021) Hermon-Taylor: M. paratuberculosis and Crohn’s Disease—The Book of Revelation According to John. Pathogens 10:11, pages 1469.
Crossref
Sailish Honap, Emma Johnston, Gaurav Agrawal, Bahij Al-Hakim, John Hermon-Taylor & Jeremy Sanderson. (2021) Anti- Mycobacterium paratuberculosis (MAP) therapy for Crohn’s disease: an overview and update . Frontline Gastroenterology 12:5, pages 397-403.
Crossref
Coad Thomas Dow. (2021) Warm, Sweetened Milk at the Twilight of Immunity - Alzheimer’s Disease - Inflammaging, Insulin Resistance, M. paratuberculosis and Immunosenescence. Frontiers in Immunology 12.
Crossref
Coad Thomas Dow & Edward D. Chan. (2021) What is the evidence that mycobacteria are associated with the pathogenesis of Sjogren’s syndrome?. Journal of Translational Autoimmunity 4, pages 100085.
Crossref
Ahmad Qasem, Erij Elkamel & Saleh A. Naser. (2020) Anti-MAP Triple Therapy Supports Immunomodulatory Therapeutic Response in Crohn’s Disease through Downregulation of NF-κB Activation in the Absence of MAP Detection. Biomedicines 8:11, pages 513.
Crossref
Helena Rouco, Patricia Diaz-Rodriguez, Diana P. Gaspar, Lídia M. D. Gonçalves, Miguel Cuerva, Carmen Remuñán-López, António J. Almeida & Mariana Landin. (2020) Rifabutin-Loaded Nanostructured Lipid Carriers as a Tool in Oral Anti-Mycobacterial Treatment of Crohn’s Disease. Nanomaterials 10:11, pages 2138.
Crossref
Karma Yeshi, Roland Ruscher, Luke Hunter, Norelle L. Daly, Alex Loukas & Phurpa Wangchuk. (2020) Revisiting Inflammatory Bowel Disease: Pathology, Treatments, Challenges and Emerging Therapeutics Including Drug Leads from Natural Products. Journal of Clinical Medicine 9:5, pages 1273.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.